Cheaper eye drug proves as good as pricier one

A new study shows that a cheaper drug for a common eye disease is as effective as a more expensive one approved for the condition.

The study found that vision improvement was the same among patients given monthly shots of Avastin (ah-VAS-tin) or Lucentis (loo-SEN-tis) for one year. The patients have an disease called wet macular degeneration - a common cause of blindness in the elderly.

Avastin is a cancer that many doctors have used to treat the eye disorder even though it wasn't approved for that use. It costs about $50 per treatment compared to $2,000 for Lucentis. Both drugs are sold by Roche's Genentech unit.

Results were published online Thursday by the and will be presented at a meeting on Sunday.


Explore further

Study finds Avastin and Lucentis are equally effective in treating AMD

©2011 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Citation: Cheaper eye drug proves as good as pricier one (2011, April 28) retrieved 19 August 2019 from https://medicalxpress.com/news/2011-04-cheaper-eye-drug-good-pricier.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more